Results 11 to 20 of about 190,833 (345)
PLoS Medicine, 2022 BackgroundOur understanding of the global scale of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection remains incomplete: Routine surveillance data underestimate infection and cannot infer on population immunity; there is a ...
Isabel Bergeri +29 more
doaj +2 more sources
Estimation of the worldwide seroprevalence of cytomegalovirus : a systematic review and meta-analysis [PDF]
Reviews in Medical Virology, 2019 Cytomegalovirus (CMV) infection does not usually produce symptoms when it causes primary infection, reinfection, or reactivation because these three types of infection are all controlled by the normal immune system.
Anderholm +31 more
core +3 more sources
SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review
BMJ Open, 2021 Objectives We aimed to review SARS-CoV-2 seroprevalence studies conducted in Europe to understand how they may be used to inform ongoing control strategies for COVID-19.Design Scoping review of peer-reviewed publications and manuscripts on preprint ...
Rebecca Grant +6 more
doaj +2 more sources
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
Nature Communications, 2020 Healthcare workers may be at higher risk of SARS-CoV-2 infection than the general population. Here, the authors report 19% seroprevalence of SARS-CoV-2 antibodies among 2,149 employees in a Swedish hospital.
Ann-Sofie Rudberg +23 more
doaj +2 more sources
MMWR. Morbidity and mortality weekly report, 2022 In December 2021, the B.1.1.529 (Omicron) variant of SARS-CoV-2, the virus that causes COVID-19, became predominant in the United States. Subsequently, national COVID-19 case rates peaked at their highest recorded levels.* Traditional methods of disease ...
K. Clarke +8 more
semanticscholar +1 more source
Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy
Hepatology, EarlyView., 2022 Abstract Background and Aims Current liver‐directed gene therapies look for adeno‐associated virus (AAV) vectors with improved efficacy. With this background, capsid engineering is explored. Whereas shuffled capsid library screenings have resulted in potent liver targeting variants with one first vector in human clinical trials, modifying natural ...
Nadja Meumann +25 more
wiley +1 more source
Seroprevalence of Noroviruses in Swine [PDF]
Journal of Clinical Microbiology, 2005 ABSTRACT Noroviruses (NVs) are important human pathogens that cause acute gastroenteritis. Genetically related animal enteric NVs have also been described, but there is no evidence of interspecies transmission of NVs. In this study we characterized antibody prevalence among domestic pigs by using recombinant capsid antigens of two human NVs ...
Tibor Farkas +7 more
openaire +3 more sources
BMC Public Health, 2022 Cytomegalovirus (CMV) is a common pathogen that affects individuals of all ages and establishes lifelong latency. Although CMV is typically asymptomatic in healthy individuals, infection during pregnancy or in immunocompromised individuals can cause ...
K. Fowler +10 more
semanticscholar +1 more source
Peste Des Petits Ruminants in Pawe District, Northwest Ethiopia: A Study on Seroprevalence and Associated Risk Factors. [PDF]
Vet Med SciGRAPHICAL ABSTRACT ❖ The overall antibody seroprevalence of PPRV in the district was 70.7% (236/334) with nonsignificant difference in the prevalence between sheep (71.3%) and goats (69.9%). ❖ Highest Kebele‐wise overall antibody seroprevalence of PPRV was recorded in Almu (82.5%), followed by Mender 14 (68.7%), and the lowest seroprevalence was ...
Abiyu Sembeto Y +2 more
europepmc +2 more sources
COVID-19 antibody seroprevalence in Santa Clara County, California
medRxiv, 2020 Background Addressing COVID-19 is a pressing health and social concern. To date, many epidemic projections and policies addressing COVID-19 have been designed without seroprevalence data to inform epidemic parameters.
E. Bendavid +16 more
semanticscholar +1 more source